Wadee A A, Cohen J, Rabson A R
S Afr Med J. 1987 Feb 7;71(3):154-6.
Sera from 123 patients with confirmed tuberculosis and 576 patients with other non-mycobacterial diseases were tested for antibodies to an adsorbed mycobacterial sonicate antigen employing an enzyme-linked immunosorbent assay. The results show significant differences in IgG levels between sera from tuberculosis patients and controls. The results of delayed hypersensitivity skin-test reactions to purified protein derivative in both the patient and control groups were unrelated to antibody levels. The assay was able to detect antibodies for at least 4 months after diagnosis and treatment. Patients diagnosed as having tuberculosis 7 months or more before being tested did not demonstrate increased antibody levels. The assay could be useful not only as a screening technique for diagnosing tuberculosis in an immunised population but also as a means of monitoring antituberculosis treatment.
采用酶联免疫吸附试验,对123例确诊为结核病的患者和576例患有其他非分枝杆菌疾病的患者的血清进行检测,以检测其对吸附的分枝杆菌超声破碎抗原的抗体。结果显示,结核病患者血清与对照组血清的IgG水平存在显著差异。患者组和对照组对纯化蛋白衍生物的迟发型超敏皮肤试验反应结果与抗体水平无关。该检测方法能够在诊断和治疗后至少4个月检测到抗体。在检测前7个月或更长时间被诊断为患有结核病的患者,其抗体水平并未升高。该检测方法不仅可作为免疫人群中结核病诊断的筛查技术,还可作为监测抗结核治疗的手段。